@article{5673e3fdb97c4fff9b06a79164ba47d1,
title = "Letter: New treatments for hepatitis C have implications for quality of life in people who inject drugs",
author = "P. Higgs and C. Wright and M. Hellard",
note = "Funding Information: Declaration of personal interests: MH and PH: Research/grant support from Gilead Sciences to the Burnet Institute to support an investigator initiated research study on treatment of PWID. Declaration of funding interests: PH was supported by a Curtin University fellowship. Gilead Sciences provided funding for the project through its Australian Fellowship Research Grants Program. The National Drug Research Institute at Curtin University was supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund. MH was supported with a NHMRC Senior Research Fellowship. CW is funded by an Australian Postgraduate Award.",
year = "2016",
month = apr,
day = "1",
doi = "10.1111/apt.13538",
language = "English",
volume = "43",
pages = "840--841",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "7",
}